The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI. - Rehman R; Froehlich A; Olde Heuvel F; Elsayed L; Boeckers T; Huber-Lang M; Morganti-Kossmann C; Roselli F (Frontiers in immunology, 2024)